The largest community of pharma leaders

Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the departure of Dr. Sheila Gujrathi from the company’s board of directors. Dr. Gujrathi has served as a board member of Five Prime since December 2015 and is stepping down from the board to focus on her role as President and Chief Executive Officer of Gossamer Bio….

 

 

http://www.businesswire.com/news/home/20190609005021/en/Prime-Therapeutics-Announces-Departure-Dr.-Sheila-Gujrathi

0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

City of Hope Distinguished Scientist Debbie Thurmond Named New Director of Diabetes & Metabolism Research Institute

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--Debbie C. Thurmond, Ph.D., has been named the...

Did You Know That One in Eight Women Are at Risk for Breast Cancer?

LEHI, Utah & SAN FRANCISCO--(BUSINESS WIRE)--Breast cancer affects one in eight...

Global Companion Diagnostic Market to Surpass US$ 12,114.6 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #CompanionDiagnostic--According to Coherent Market Insights, the global companion diagnostic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.